Vyvanse - Adhd Med.
Vyvanse is effective in treating adults with attention-deficit/hyperactivity disorder, according to new clinical trial results. In the study, 414 adults ages 18 to 55 who took the med daily for four weeks showed improvement in core ADHD symptoms, according to Shire. The Food and Drug Administration has already approved Vyvanse for the treatment of ADHD in children.
Read moreMore information on "Vyvanse - Adhd Med."
From Our Sources
FDA approves Vyvanse for adult ADHD
The U.S. Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity disorder in adults. Vyvanse is a new... Read more »
Maker of Vyvanse wants med approved for adults
Shire, the maker of Vyvanse, has filed for U.S. approval to treat adult attention-deficit/hyperactivity disorder with their new ADHD medication.... Read more »
Vyvanse one step closer to approval
The new attention-deficit/hyperactivity disorder (ADHD) medication Vyvanse has received another approval letter from the Food and Administration... Read more »
Vyvanse released on U.S. market
Vyvanse, the daily medication to treat symptoms of attention-deficit/hyperactivity disorder, is now available in the United States. Vyvanse works... Read more »
Study: Vyvanse controls ADHD symptoms
A new study by the maker of Vyvanse found that the medication controlled attention- deficit/hyperactivity disorder symptoms in children 6 to 12 years... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
